Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2022

Aquisição de ANIDULAFUNGINA,IV,100MG,PO SOL INJ, ao abrigo do CPA 2021/41, para o HFF, para o ano 2022

Contract value
€1,680.00
Signed on
27 April 2022
Procedure
Prior consultation (Consulta Prévia)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9386767

PUBLISHED SUBJECT

Aquisição de ANIDULAFUNGINA,IV,100MG,PO SOL INJ, ao abrigo do CPA 2021/41, para o HFF, para o ano 2022

Parties involved

Place of performance
Portugal, Lisboa, Amadora
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Bidder
FRESENIUS KABI PHARMA PORTUGAL, LDA. · Tax ID 504293753
Bidder
ACCORD HEALTHCARE, UNIPESSOAL, LDA · Tax ID 508622263

Values and timeline

Contract price
€1,680.00
Procedure base price
€1,800.00
Total effective price
Not reported on Portal BASE
Publication date
27 July 2022
Award date
22 April 2022
Signing date
27 April 2022
Performance period
248 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Prior consultation (Consulta Prévia)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
5900772

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts